Yossi Maimon
2014 - Protalix BioTherapeutics
In 2014, Yossi Maimon earned a total compensation of $860K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $56,170 |
| Salary | $299,090 |
| Stock Awards | $205,244 |
| Other | $74,493 |
| Total | $859,997 |
Maimon received $299.1K in salary, accounting for 35% of the total pay in 2014.
Maimon also received $225K in bonus, $56.2K in option awards, $205.2K in stock awards and $74.5K in other compensation.
Rankings
In 2014, Yossi Maimon's compensation ranked 8,233rd out of 13,032 executives tracked by ExecPay. In other words, Maimon earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,233 out of 13,032 | 37th |
Division Manufacturing | 3,049 out of 4,967 | 39th |
Major group Chemicals And Allied Products | 1,037 out of 1,690 | 39th |
Industry group Drugs | 816 out of 1,369 | 40th |
Industry Biological Products, Except Diagnostic Substances | 145 out of 241 | 40th |
Source: SEC filing on March 16, 2017.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2014.
2014
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2014
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2014
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
2014
Moshe Manor
Protalix BioTherapeutics